Introduction Semaglutide, a groundbreaking medication primarily used for managing type 2 diabetes and obesity, has gained significant traction in Sweden. As a glucagon-like peptide-1 (GLP-1) receptor agonist, it helps regulate blood sugar levels and promotes weight loss, making it a preferred choice among patients and healthcare providers. The Sweden Semaglutide Market is poised for...